Last reviewed · How we verify
Efficacy of Organoid-Based Chemotherapy Drug Precision Screening to Guide Treatment for Thyroid Cancer
The current study aims to explore the potential advantages of chemotherapy that is implemented based on drug sensitivity testing. This pertains to individuals with locally advanced or metastatic poorly differentiated or anaplastic thyroid cancer who have undergone conventional therapy in the past or unresectable patients .
Details
| Lead sponsor | West China Hospital |
|---|---|
| Phase | PHASE2 |
| Status | NOT_YET_RECRUITING |
| Enrolment | 20 |
| Start date | Sun Dec 01 2024 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Wed Jul 01 2026 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- Locally Advanced Thyroid Gland Carcinoma
- Thyroid Cancer
Interventions
- Cyclophosphamide+Pemetrexed+5-Fluorouracil
- Cyclophosphamide+Doxorubicin+5-Fluorouracil
- Vindesine + Cisplatin
- Doxorubicin + Cisplatin
- Doxorubicin + Cyclophosphamide + Cisplatin
- Docetaxel + Doxorubicin
- Paclitaxel + Carboplatin
- Paclitaxel + Doxorubicin
- Paclitaxel + Cisplatin
- Gemcitabine alone
Countries
China